RUSAPEFGENE PLASMIVEC
UNII B2LGE6L9SK

Substance Identification & Data

This profile provides standardized clinical and technical data for Rusapefgene Plasmivec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B2LGE6L9SK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3053183-38-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
B2LGE6L9SK
CAS Registry Number
3053183-38-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
RUSAPEFGENE PLASMIVEC
Official standardized name for this substance within the FDA UNII nomenclature system.
INN ID
13872
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rusapefgene Plasmivec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RUSAPEFGENE PLASMIVEC

Common Names & Synonyms

DNA (RECOMBINANT PLASMID VECTOR PUDK-HGF HUMAN CYTOMEGALOVIRUS ENHANCER AND PROMOTER REGION PLUS HUMAN HEPATOCYTE GROWTH FACTOR TRANSGENE PLUS BOS TAURUS GROWTH HORMONE POLYADENYLATION SIGNAL PLUS PBR322 REPLICATION ORIGIN PLUS KANAMYCIN RESISTANCE GENE-SPECIFYING)
DNA PLASMID ENCODING HUMAN HEPATOCYTE GROWTH FACTOR (HGF) UNDER CONTROL OF A CYTOMEGALOVIRUS (CMV) ENHANCER/PROMOTER AND TERMINATED BY A BOVINE GROWTH HORMONE (BGH) POLYADENYLATION SIGNAL. THE PLASMID ALSO CONTAINS A PBR322 ORIGIN OF REPLICATION AND A KANAMYCIN RESISTANCE GENE
RUSAPEFGENE PLASMIVEC [INN]